A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-05-08
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of HR17031 injection and insulin glargine, including the changes of efficacy indicators such as HbA1c, fasting blood glucose, body weight and safety indicators such as adverse events and hypoglycemic events.